Temozolomide-loaded PLGA nanoparticles to treat glioblastoma cells: a biophysical and cell culture evaluation

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Neurological Research

• Publication date

  2016-01-02

• Fields of study

  Medicine, Chemistry, Engineering

• Identifiers
  DOI 10.1080/01616412.2015.1133025PMID 26905383
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Chemotherapy for Malignant Gliomas

  2014cited by this paper
• Temozolomide loaded PLGA-based superparamagnetic nanoparticles for magnetic resonance imaging and treatment of malignant glioma.

  2012cited by this paper
• The Effect of Temozolomide/Poly(lactide-co-glycolide) (PLGA)/Nano-Hydroxyapatite Microspheres on Glioma U87 Cells Behavior

  2012cited by this paper
• Impact of Temozolomide on Immune Response during Malignant Glioma Chemotherapy

  2012cited by this paper
• Irinophore C™, a lipid-based nanoparticulate formulation of irinotecan, is more effective than free irinotecan when used to treat an orthotopic glioblastoma model.

  2012cited by this paper
• Mathematical modeling of drug delivery from autocatalytically degradable PLGA microspheres--a review.

  2012cited by this paper
• The Trojan Horse Liposome Technology for Nonviral Gene Transfer across the Blood-Brain Barrier

  2011cited by this paper
• MGMT-independent temozolomide resistance in pediatric glioblastoma cells associated with a PI3-kinase-mediated HOX/stem cell gene signature.

  2010cited by this paper
• Pharmacodynamics of cisplatin-loaded PLGA nanoparticles administered to tumor-bearing mice.

  2010cited by this paper
• Gene expression profiling predicts response to temozolomide in malignant gliomas.

  2010cited by this paper
• Enhanced permeability and retention (EPR) effect for anticancer nanomedicine drug targeting.

  2010cited by this paper
• Transferrin- and transferrin-receptor-antibody-modified nanoparticles enable drug delivery across the blood-brain barrier (BBB).

  2009cited by this paper
• A new double emulsion solvent diffusion technique for encapsulating hydrophilic molecules in PLGA nanoparticles.

  2009cited by this paper
• Malignant gliomas in adults.

  2008cited by this paper
• Transferrin‐conjugated solid lipid nanoparticles for enhanced delivery of quinine dihydrochloride to the brain

  2007cited by this paper
• Temozolomide/PLGA microparticles and antitumor activity against glioma C6 cancer cells in vitro.

  2007cited by this paper
• Preparation of insulin loaded PLGA-Hp55 nanoparticles for oral delivery.

  2007cited by this paper
• Cationic albumin-conjugated pegylated nanoparticles allow gene delivery into brain tumors via intravenous administration.

  2006cited by this paper
• Sustained release of dexamethasone from hydrophilic matrices using PLGA nanoparticles for neural drug delivery.

  2006cited by this paper
• Brain cancer diagnosis and therapy with nanoplatforms.

  2006cited by this paper
• Paclitaxel nanoparticles for the potential treatment of brain tumors.

  2004cited by this paper
• Intra-arterial delivery of endostatin gene to brain tumors prolongs survival and alters tumor vessel ultrastructure

  2004cited by this paper
• Brain uptake of thiamine-coated nanoparticles.

  2003cited by this paper
• Plasma and Cerebrospinal Fluid Pharmacokinetics of Intravenous Temozolomide in Non-human Primates

  2003cited by this paper
• Blood-brain barrier drug targeting: the future of brain drug development.

  2003cited by this paper
• Transferrin Receptor Ligand-Targeted Toxin Conjugate (Tf-CRM107) for Therapy of Malignant Gliomas

  2003cited by this paper
• Drug and gene targeting to the brain with molecular trojan horses

  2002cited by this paper
• Intravenous Administration to Rabbits of Non-stealth and Stealth Doxorubicin-loaded Solid Lipid Nanoparticles at Increasing Concentrations of Stealth Agent: Pharmacokinetics and Distribution of Doxorubicin in Brain and Other Tissues

  2002cited by this paper
• BBB-Genomics: creating new openings for brain-drug targeting.

  2001cited by this paper
• The blood-brain and blood-tumor barriers: a review of strategies for increasing drug delivery.

  2000cited by this paper
• Significant Transport of Doxorubicin into the Brain with Polysorbate 80-Coated Nanoparticles

  1999cited by this paper
• Microvessel organization and structure in experimental brain tumors: microvessel populations with distinctive structural and functional properties.

  1999cited by this paper
• Biodegradable Nanoparticles Containing Doxorubicin-PLGA Conjugate for Sustained Release

  1999cited by this paper
• Receptor mediated delivery of daunomycin using immunoliposomes: pharmacokinetics and tissue distribution in the rat.

  1997cited by this paper
• Temozolomide: a review of its discovery, chemical properties, pre-clinical development and clinical trials.

  1997cited by this paper
• Pharmacological blood-brain barrier modification for selective drug delivery

  1995cited by this paper
• Passage of peptides through the blood-brain barrier with colloidal polymer particles (nanoparticles).

  1995cited by this paper
• Chemotherapy for malignant gliomas.

  1988cited by this paper

• Mechanistic Modelling of Transdermal Delivery Dependence on Drug Properties.

  2026cites this paper
• Preparation and evaluation of temozolomide loaded PLGA nanoparticles for the treatment of glioblastoma multiforme

  2025cites this paper
• Co-encapsulation of temozolomide and PbS quantum dots in apoferritin for transferrin receptor 1 targeting, imaging and treatment of glioblastoma

  2025cites this paper
• LinTT1-Functionalized Hybrid Lipid-Polymer Nanoparticles for Glioblastoma Targeting.

  2025cites this paper
• Overcoming standard-of-care resistance in glioblastoma using nanoparticle-based drug delivery targeting the autophagy pathway.

  2025cites this paper
• Chemotherapeutic nanoparticles for glioblastoma

  2025cites this paper
• A modern approach to glioblastoma using temozolomide and nanoparticles carrier drug: a standard care of combination therapy and treatment.

  2025cites this paper
• Development and Evaluation of Temozolomide Loaded polymeric Nanoparticles Functionalized with a Dendrimer and Hyaluronic Acid: An Innovative Nanotherapeutics for Glioblastoma Multiforme

  2025cites this paper
• PLGA nanoparticles as promising drug delivery carrier: the future of skin cancer treatment

  2025cites this paper
• Advancements in Magnesium Applications, Biocompatible Implants to Nanoparticles in Medicine and Biomedical Innovations

  2025cites this paper
• Radiosensitizing properties of dual-functionalized carbon nanostructures loaded with temozolomide

  2025cites this paper
• Promising Anticancer Activity of Pyrazole Compounds against Glioblastoma Multiforme: Their Synthesis, In vitro, and Molecular Docking Studies.

  2025cites this paper
• Exploratory Study on Nanoparticle Co-Delivery of Temozolomide and Ligustilide for Enhanced Brain Tumor Therapy

  2025cites this paper
• Review of the Applications of Micro/Nanorobots in Biomedicine

  2024cites this paper
• Nose-to-Brain Delivery of Biomimetic Nanoparticles for Glioblastoma Targeted Therapy

  2024cites this paper
• Cancer cell membrane-camouflaged biomimetic nanoparticles for enhancing chemo-radiation therapy efficacy in glioma

  2024cites this paper
• Exploring temozolomide encapsulated PEGylated Liposomes and Lyotropic liquid crystals for effective treatment of glioblastoma: in-vitro, cell line, and pharmacokinetic studies.

  2023cites this paper
• Development and characterization of a temozolomide-loaded nanoemulsion and the effect of ferrocene pre and co-treatments in glioblastoma cell models

  2023cites this paper
• A two-pronged approach against glioblastoma: drug repurposing and nanoformulation design for in situ-controlled release

  2023cites this paper
• Strategies increasing the effectiveness of temozolomide at various levels of anti-GBL therapy.

  2023cites this paper
• Agent-Based Modelling Reveals the Role of the Tumor Microenvironment on the Short-Term Success of Combination Temozolomide/Immune Checkpoint Blockade to Treat Glioblastoma

  2023influential citation
• The interplay of solvent-drug-protein interactions during albumin nanoparticles formulations for temozolomide delivery to brain cancer cells.

  2023cites this paper
• Current advances in temozolomide encapsulation for the enhancement of glioblastoma treatment

  2023cites this paper
• A biopolymeric mesh enriched with PLGA microparticles loaded with AT101 for localized glioblastoma treatment

  2023cites this paper
• Using design of experiments (DoE) to optimize performance and stability of biomimetic cell membrane-coated nanostructures for cancer therapy

  2023cites this paper
• Polymeric Nanoparticles—Tools in a Drug Delivery System in Selected Cancer Therapies

  2022cites this paper
• Transferrin-modified nanoparticles for targeted delivery of Asiatic acid to glioblastoma cells.

  2022cites this paper
• Self-assembled dehydropeptide nanocarrier as a delivery system for antitumor drug temozolomide.

  2022cites this paper
• Evaluation Of Drug Release Kinetics Of Temozolomide Loaded PLGA Nanoparticles In Pluronic® F-127 Hydrogel

  2022cites this paper
• Temozolomide: an Overview of Biological Properties, Drug Delivery Nanosystems, and Analytical Methods.

  2022cites this paper
• Nanomedicine for Glioblastoma: Progress and Future Prospects.

  2022cites this paper
• Controlled release and targeted drug delivery with poly(lactic-co-glycolic acid) nanoparticles: reviewing two decades of research

  2022cites this paper
• Preparation of size-tunable sub-200 nm PLGA-based nanoparticles with a wide size range using a microfluidic platform

  2022cites this paper
• Temozolomide hexadecyl ester targeted plga nanoparticles for drug-resistant glioblastoma therapy via intranasal administration

  2022cites this paper
• Polymeric and small molecule-conjugates of temozolomide as improved therapeutic agents for glioblastoma multiforme.

  2022cites this paper
• Synthesis and Characterization of Erythromycin Loaded PLGA and PCL Microspheres: Antimicrobial Application

  2021cites this paper
• GRGDS-conjugated and curcumin-loaded magnetic polymeric nanoparticles for the hyperthermia treatment of glioblastoma cells

  2021cites this paper
• Genistein and Temozolomide-Loaded Polymeric Nanoparticles: A Synergistic Approach For Improved Anti-Tumor Efficacy Against Glioblastoma

  2021cites this paper
• Role of microRNA therapy in presensitizing glioblastoma cells to temozolomide treatment

  2021cites this paper
• Hyaluronic acid conjugated albumin nanoparticles for efficient receptor mediated brain targeted delivery of temozolomide

  2020cites this paper
• Temozolomide: An Updated Overview of Resistance Mechanisms, Nanotechnology Advances and Clinical Applications

  2020cites this paper
• Enhanced Caspase-Mediated Abrogation of Autophagy by Temozolomide-Loaded and Panitumumab-Conjugated Poly(lactic-co-glycolic acid) Nanoparticles in Epidermal Growth Factor Receptor Overexpressing Glioblastoma Cells.

  2020cites this paper
• The Cellular Uptake, Distribution and Toxicity of Poly (lactic-co-glycolic) Acid Nanoparticles in Medicago sativa Suspension Culture

  2020cites this paper
• Temozolomide, Gemcitabine and Decitabine Hybrid Nano-conjugates: From design to proof of concept (PoC) of synergies: towards the undestanding of drug impact in Human Glioblastoma Cells.

  2020cites this paper
• Synthesis of PHB-co-PEI nanoparticles as gene carriers for miR-128-encoding plasmid delivery to U87 glioblastoma cells

  2020cites this paper
• Development and in vitro evaluation of temozolomide-loaded PLGA nanoparticles in a thermoreversible hydrogel system for local administration in glioblastoma multiforme

  2020cites this paper
• The Design of Poly(lactide-co-glycolide) Nanocarriers for Medical Applications

  2020cites this paper
• Chondroitin sulfate conjugation facilitates tumor cell internalization of albumin nanoparticles for brain-targeted delivery of temozolomide via CD44 receptor-mediated targeting

  2020cites this paper
• Targeting Glioblastoma: Advances in Drug Delivery and Novel Therapeutic Approaches

  2020cites this paper
• Cetuximab conjugated temozolomide-loaded poly (lactic-co-glycolic acid) nanoparticles for targeted nanomedicine in EGFR overexpressing cancer cells

  2020cites this paper
• Development of transferrin-modified poly(lactic-co-glycolic acid) nanoparticles for glioma therapy

  2019cites this paper
• Effects of solvent used for fabrication on drug loading and release kinetics of electrosprayed temozolomide-loaded PLGA microparticles for the treatment of glioblastoma.

  2019cites this paper
• Core-shell type thermo-nanoparticles loaded with temozolomide combined with photothermal therapy in melanoma cells

  2019cites this paper
• Polymeric and lipid-based drug delivery systems for treatment of glioblastoma multiforme

  2019cites this paper
• Factorial Design as a Tool for the Optimization of PLGA Nanoparticles for the Co-Delivery of Temozolomide and O6-Benzylguanine

  2019cites this paper
• Analysis of chemotherapeutic-induced tumor dormancy in Glioblastoma Multiforme and alternative therapy approaches

  2019cites this paper
• A Drug‐Eluting 3D‐Printed Mesh (GlioMesh) for Management of Glioblastoma

  2019cites this paper
• Targeted nanoparticle delivery of therapeutic antisense microRNAs presensitizes glioblastoma cells to lower effective doses of temozolomide in vitro and in a mouse model

  2018cites this paper
• Receptor‐mediated PLGA nanoparticles for glioblastoma multiforme treatment

  2018cites this paper
• Solid Lipid Nanoparticles Carrying Temozolomide for Melanoma Treatment. Preliminary In Vitro and In Vivo Studies

  2018cites this paper
• Prolonged drug release using PCL–TMZ nanofibers induce the apoptotic behavior of U87 glioma cells

  2018cites this paper
• Intracellular microRNA quantification in intact cells: a novel strategy based on reduced graphene oxide-based fluorescence quenching

  2018cites this paper
• PLGA-Based Nanoparticles in Cancer Treatment

  2018cites this paper
• Development of a drug-eluting 3D bioprinted mesh (GlioMesh) for treatment of glioblastoma multiforme

  2018cites this paper
• Development of temozolomide coated nano zinc oxide for reversing the resistance of malignant glioma stem cells.

  2018cites this paper
• Enhancement of temozolomide stability by loading in chitosan-carboxylated polylactide-based nanoparticles

  2017cites this paper
• Biodegradable microrobots for targeting cell delivery.

  2017cites this paper
• New strategies for cancer management: how can temozolomide carrier modifications improve its delivery?

  2017cites this paper
• Conception et caractérisation de nanoparticules polymères théragnostiques destinées au traitement des tumeurs cérébrales

  2017cites this paper
• Overcoming blood brain barrier with a dual purpose Temozolomide loaded Lactoferrin nanoparticles for combating glioma (SERP-17-12433)

  2017cites this paper
• Tailored Nanoparticle Codelivery of antimiR-21 and antimiR-10b Augments Glioblastoma Cell Kill by Temozolomide: Toward a "Personalized" Anti-microRNA Therapy.

  2016cites this paper
• Special Section on Quantitative Systems Pharmacology: A Foundation to Establish Precision Medicine Agent-Based Modelling Reveals the Role of the Tumor Microenvironment on the Short-Term Success of Combination Temozolomide/Immune Checkpoint Blockade to Treat Glioblastoma S

  year unknowncites this paper